Catheters Market Overview:
The global catheters market was valued at $10,703 million in 2017 and is estimated to reach $19,976 million by 2025, registering a CAGR of 8.0 % from 2018 to 2025.
Catheters are the medical devices that are made up of medical grade material and are used for both diagnosis as well as treatment purposes. These are usually made of plastic, silicon rubber, polyvinyl chloride (PVC), and nylon, and can easily be inserted in the patients body. Catheters primarily allow drainage, administration of fluids in the patients body and are used to perform numerous other tasks depending on the type of catheter including cardiovascular, neurovascular, urological, and others.
High prevalence of cardiovascular diseases accompanied with the development of innovative cardiovascular catheters is the major factor that drives the market growth. Increase in prevalence of urological diseases such as urinary bladder cancer and kidney failure, has significantly fueled the demand for urological catheters. Also, novel products such as external male catheters, have proved to be a lucrative addition to the overall catheters and variants product lines for the catheters manufacturing companies. The increase in patient pool for ischemic and hemorrhagic stroke thereby increased the demand for minimally invasive neurovascular surgeries, thus making way for opportunities for the neurovascular catheters micro catheters and guiding catheters. Increase in cardiovascular diseases and growth in demand for minimal invasive surgeries drive the global catheters market. Rise in incidence of diabetes, cardiovascular diseases, urinary bladder, and kidney failures also fuel the market growth.
The catheters market is segmented based on product and region. Based on product, the market is divided into cardiovascular catheters, neurovascular catheters, urological catheters, intravenous catheters, specialty catheters. Based on region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Benefits of Catheters Market:
The study provides an in-depth analysis of the global catheters market along with the current trends and future estimations to elucidate the imminent investment pockets.
A comprehensive analysis of the factors that drive and restrict the market growth is provided.
A comprehensive quantitative analysis of the industry is provided from 2018 to 2025 to assist stakeholders to capitalize on the prevailing market opportunities.
An extensive analysis of the key segments of the industry helps understand the global trends in the catheters market.
Key players and their strategies are provided to understand the competitive outlook of the industry.
Catheters Market Key Segments:
By Product
Cardiovascular Catheters
Electrophysiology Catheters
PTCA Balloons Catheters
IVUS Catheters
PTA Balloons Catheters
Others
Neurovascular Catheters
Urological Catheters
Dialysis Catheter
Hemodialysis Catheters
Peritoneal Catheters
Dialysis Catheter
Foley Catheters
Intermittent Catheters
External Catheters
Intravenous Catheters
Central Venous Catheters
Peripheral Venous Catheters
Integrated Catheters
Short Catheters
Specialty Catheters
Wound/Surgical Drain
Oximetry
Thermodilution
IUI Catheters
By Region
North America
U.S.
Canada
Mexico
Europe
UK
France
Germany
Italy
France
Rest of Europe
Asia-Pacific
Japan
China
India
South Korea
Australia
Rest of Asia-Pacific
LAMEA
Saudi Arabia
South Africa
Brazil
Rest of LAMEA
Key Market Players
Abbott Laboratories
Becton Dickinson And Company
Boston Scientific Corporation
Stryker Corporation
B. Braun Melsungen AG
Teleflex Incorporated
Johnson & Johnson
Medtronic, Inc
Edwards Lifesciences Corp
Cook Medical
The other players in the value chain include (profiles not included in the report)
Hollister Incorporated
Manfred Sauer
Smiths Medical
Wellspect Healthcare
Cure Medical
Convatech Inc
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top Winning Strategies
3.3. Patent Analysis
3.3.1. Patent analysis by geography (2016-2018)
3.3.2. Patent analysis by applicants (2015-2016)
3.4. Clinical Trials For Catheters
3.5. Porters five forces analysis
3.6. Value chain analysis
3.6.1. Primary activities
3.6.2. Support activities
3.7. Market share analysis, 2017
3.8. Government regulations and reimbursements
3.8.1. Catheter regulation in the U.S. and Europe
3.8.2. Reimbursements
3.8.2.1. U.S.
3.8.3. Europe
3.9. Market dynamics
3.9.1. Drivers
3.9.1.1. Growing demand for minimally invasive procedures
3.9.1.2. Increase in adoption of catheters
3.9.1.3. Surge in geriatric population
3.9.2. Restraints
3.9.2.1.Rise in Catheter-associated Urinary Tract Infections (CAUTI)
3.9.2.2.Inadequate quality assurance
3.9.3. Opportunities
3.9.3.1. Opportunities in emerging economies
CHAPTER 4: CATHETERS MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Cardiovascular Catheters
4.2.1. Key market trends and opportunity
4.2.2. Market size and forecast
4.2.3. Electrophysiology Catheters
4.2.3.1. Market size and forecast
4.2.4. PTCA Balloons Catheters
4.2.4.1. Market size and forecast
4.2.5. Intravascular ultrasound (IVUS) Catheters
4.2.5.1. Market size and forecast
4.2.6. Percutaneous transluminal angioplasty (PTA) balloon Catheters
4.2.6.1. Market size and forecast
4.2.7. Others
4.2.7.1. Market size and forecast
4.2.7.1.1. Guiding Catheters
4.2.7.1.2. Angiography catheters
4.2.7.1.3. Pulmonary artery catheters
4.3. Neurovascular Catheters
4.3.1. Key Market Trends and Opportunity
4.3.2. Market size and forecast
4.4. Urological Catheters
4.4.1. Key Market Trends and Opportunities
4.4.2. Market size and forecast
4.4.3. Dialysis catheter
4.4.3.1. Market size and forecast
4.4.3.2. Hemodialysis catheter
4.4.3.2.1. Market size and forecast
4.4.3.3. Peritoneal catheter
4.4.3.3.1. Market size and forecast
4.4.4. Urinary catheter
4.4.4.1. Market size and forecast
4.4.4.2. Foley Catheters
4.4.4.2.1. Market size and forecast
4.4.4.3. Intermittent Catheters
4.4.4.3.1. Market size and forecast
4.4.4.4. External Catheters
4.4.4.4.1. Market size and forecast
4.5. Intravenous Catheters
4.5.1. Key market trends and opportunities
4.5.2. Market size and forecast
4.5.3. Central venous catheters
4.5.3.1. Market size and forecast
4.5.4. Peripheral venous catheters
4.5.4.1. Market size and forecast
4.5.4.2. Integrated Catheters
4.5.4.2.1. Market size and forecast
4.5.4.3. Short Catheter
4.5.4.3.1. Market size and forecast
4.6. Specialty Catheters
4.6.1. Key market trends and opportunity
4.6.2. Market size and forecast
4.6.3. Wound / Surgical drain
4.6.3.1. Market size and forecast
4.6.4. Oximetry
4.6.4.1. Market size and forecast
4.6.5. Thermodilution
4.6.5.1. Market size and forecast
4.6.6. IUI catheters
4.6.6.1. Market size and forecast
CHAPTER 5: CATHETERS MARKET, BY REGION
5.1. Overview
5.1.1. Market size and forecast
5.2. North America
5.2.1. Key trends and opportunities
5.2.2. North America market size & forecast, by product
5.2.3. North America market size & forecast, by country
5.2.3.1. U.S. market size & forecast
5.2.3.2. Canada market size & forecast
5.2.3.3. Mexico market size & forecast
5.3. Europe
5.3.1. Key trends and opportunities
5.3.2. Europe market size & forecast, by product
5.3.3. Europe market size & forecast for catheters market, by country
5.3.3.1. Germany market size & forecast
5.3.3.2. France market size & forecast
5.3.3.3. UK market size & forecast
5.3.3.4. Italy market size & forecast
5.3.3.5. Russia market size & forecast
5.3.3.6. Rest of Europe market size & forecast
5.4. Asia-Pacific
5.4.1. Key trends and opportunities
5.4.2. Asia-Pacific market size & forecast, by country
5.4.3. Asia-Pacific market size & forecast, by product
5.4.3.1. Australia market size & forecast
5.4.3.2. China market size & forecast
5.4.3.3. India market size & forecast
5.4.3.4. Japan market size & forecast
5.4.3.5. Rest of Asia-Pacific market size & forecast
5.5. LAMEA
5.5.1. Key trends and opportunities
5.5.2. LAMEA market size & forecast, by country
5.5.3. LAMEA market size & forecast, by product
5.5.3.1. Brazil market size & forecast
5.5.3.2. Saudi Arabia market size & forecast
5.5.3.3. Turkey market size & forecast
5.5.3.4. Rest of LAMEA market size & forecast
CHAPTER 6: COMPANY PROFILES
6.1. Abbott Laboratories
6.1.1. Company overview
6.1.2. Company snapshot
6.1.3. Operating business segments
6.1.4. Product portfolio
6.1.5. Business performance
6.1.6. Key strategic moves and developments
6.2. B. Braun Melsungen AG
6.2.1. Company overview
6.2.2. Company snapshot
6.2.3. Operating business segments
6.2.4. Product portfolio
6.2.5. Business performance
6.3. Becton, Dickinson and Company
6.3.1. Company overview
6.3.2. Company snapshot
6.3.3. Operating business segments
6.3.4. Product portfolio
6.3.5. Business performance
6.3.6. Key strategic moves and developments
6.4. Boston Scientific Corporation
6.4.1. Company overview
6.4.2. Company snapshot
6.4.3. Operating business segments
6.4.4. Product portfolio
6.4.5. Business performance
6.4.1. Key strategic moves and developments
6.5. Johnson & Johnson
6.5.1. Company overview
6.5.2. Company snapshot
6.5.3. Operating business segments
6.5.4. Product portfolio
6.5.5. Business performance
6.5.6. Key strategic moves and developments
6.6. Medtronic Plc.
6.6.1. Company overview
6.6.2. Company snapshot
6.6.3. Operating business segment
6.6.4. Product portfolio
6.6.5. Business performance
6.6.6. Key strategic moves and developments
6.7. Edwards Lifesciences Corporation
6.7.1. Company overview
6.7.2. Company snapshot
6.7.3. Operating business segments
6.7.4. Product portfolio
6.7.5. Business performance
6.8. Teleflex Incorporated
6.8.1. Company overview
6.8.2. Company snapshot
6.8.3. Operating business segments
6.8.4. Product portfolio
6.8.5. Business performance
6.9. Cook Medical Inc.
6.9.1. Company overview
6.9.2. Company snapshot
6.9.3. Operating business segments
6.9.4. Product portfolio
6.10. Stryker Corporation
6.10.1. Company overview
6.10.2. Company snapshot
6.10.3. Operating business segments
6.10.4. Product portfolio
6.10.5. Business performance
6.10.6. Key strategic moves and developments